[PHAT] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[PHAT] Phathom Pharmaceuticals, Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -5.56%
YoY- 27.51%
Quarter Report
PHAT's Result
PHAT's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 16,352 0 0 0 0 0 0 -
PBT -85,577 -43,243 -51,091 -36,662 -34,105 -68,112 -290 157.80%
Tax 0 7,266 8,562 -563 1,282 1,561 4 -
NP -85,577 -43,243 -59,653 -36,662 -34,105 -68,112 -290 157.80%
Tax Rate - - - - - - - -
Total Cost 101,929 43,243 59,653 36,662 34,105 68,112 290 165.41%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -523.34 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -1.32 -0.76 -1.54 -0.98 -1.02 -2.98 -0.03 87.78%
EPS Diluted -1.32 -0.76 -1.54 -0.98 -1.02 -2.98 -0.03 87.78%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.